Authors:
Ferrajoli, A
Manshouri, T
Estrov, Z
Keating, MJ
O'Brien, S
Lerner, S
Beran, M
Kantarjian, HM
Freireich, EJ
Albitar, M
Citation: A. Ferrajoli et al., High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia, CLIN CANC R, 7(4), 2001, pp. 795-799
Authors:
Giles, FJ
Shen, Y
Kantarjian, HM
Korbling, MJ
O'Brien, S
Anderlini, P
Donato, M
Pierce, S
Keating, MJ
Freireich, EJ
Estey, E
Citation: Fj. Giles et al., Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival, LEUK LYMPH, 42(1-2), 2001, pp. 67-73
Authors:
Gao, Q
Horwitz, M
Roulston, D
Hagos, F
Zhao, ND
Freireich, EJ
Golomb, HM
Olopade, OI
Citation: Q. Gao et al., Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q, GENE CHROM, 28(2), 2000, pp. 164-172
Authors:
Huh, YO
Smith, TL
Collins, P
Bueso-Ramos, C
Albitar, M
Kantarjian, HM
Pierce, SA
Freireich, EJ
Citation: Yo. Huh et al., Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry, LEUK LYMPH, 37(3-4), 2000, pp. 319-331
Authors:
Keating, MJ
Smith, TL
Lerner, S
O'Brien, S
Robertson, LE
Kantarjian, H
Freireich, EJ
Citation: Mj. Keating et al., Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia, LEUK LYMPH, 37(1-2), 2000, pp. 71-85
Authors:
Haidar, MA
Manshouri, T
Keating, MJ
Kantarjian, HM
Freireich, EJ
Mehta, K
Albitar, M
Citation: Ma. Haidar et al., Downregulation of the p53 tumor suppressor gene and upregulation of the bcl-2 gene in retinoic acid receptor alpha-deficient transgenic mice, INT J ONCOL, 16(3), 2000, pp. 561-565
Authors:
Kantarjian, HM
O'Brien, S
Smith, TL
Cortes, J
Giles, FJ
Beran, M
Pierce, S
Huh, Y
Andreeff, M
Koller, C
Ha, CS
Keating, MJ
Murphy, S
Freireich, EJ
Citation: Hm. Kantarjian et al., Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia, J CL ONCOL, 18(3), 2000, pp. 547-561
Citation: Db. Jendiroba et Ej. Freireich, Granulocyte transfusions: from neutrophil replacement to immunereconstitution, BLOOD REV, 14(4), 2000, pp. 219-227
Authors:
Keyhani, A
Huh, YO
Jendiroba, D
Pagliaro, L
Cortez, J
Pierce, S
Pearlman, M
Estey, E
Kantarjian, H
Freireich, EJ
Citation: A. Keyhani et al., Increased CD38 expression is associated with favorable prognosis in adult acute leukemia, LEUK RES, 24(2), 2000, pp. 153-159
Authors:
Kozuch, P
Talpaz, M
Faderl, S
O'Brien, S
Freireich, EJ
Kantarjian, H
Citation: P. Kozuch et al., Avascular necrosis of the femoral head in chronic myeloid leukemia patients treated with interferon-alpha - A synergistic correlation?, CANCER, 89(7), 2000, pp. 1482-1489
Authors:
Weinkauff, R
Estey, EH
Starostik, P
Hayes, K
Huh, YO
Hirsch-Ginsberg, C
Andreeff, M
Keating, M
Kantarjian, HM
Freireich, EJ
Albitar, M
Citation: R. Weinkauff et al., Use of peripheral blood blasts vs bone marrow blasts for diagnosis of acute leukemia, AM J CLIN P, 111(6), 1999, pp. 733-740
Authors:
Aboul-Nasr, R
Estey, EH
Kantarjian, HM
Freireich, EJ
Andreeff, M
Johnson, BJ
Albitar, M
Citation: R. Aboul-nasr et al., Comparison of touch imprints with aspirate smears for evaluating bone marrow specimens, AM J CLIN P, 111(6), 1999, pp. 753-758
Authors:
Sacchi, S
Kantarjian, HM
Freireich, EJ
O'Brien, SO
Cortes, J
Rios, MB
Kornblau, S
Giles, FJ
Koller, C
Gajewski, J
Talpaz, M
Citation: S. Sacchi et al., Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia, LEUK LYMPH, 35(5-6), 1999, pp. 483-489
Authors:
Albitar, M
Manshouri, T
Kantarjian, H
Keating, M
Estrov, Z
Faber, J
Freireich, EJ
Pierce, S
Estey, E
Citation: M. Albitar et al., Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia, LEUK RES, 23(1), 1999, pp. 63-69
Authors:
Cortes, JE
Kantarjian, HM
O'Brien, S
Giles, F
Keating, MJ
Freireich, EJ
Estey, EH
Citation: Je. Cortes et al., A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission, CANCER, 85(7), 1999, pp. 1506-1513
Citation: Db. Jendiroba et al., The use of hematopoietic growth factors for recruitment of leukocytes for transfusion, CLINICAL APPLICATIONS OF CYTOKINES AND GROWTH FACTORS, 1999, pp. 178-185